Skip to main content

Setting the stage: A virtual roundtable on the need for EDIIA in cancer care and clinical trials

A virtual roundtable on the need for EDIIA in cancer care
Please join CCTG on January 12, 2024 from 12:00-1:30 EST for a virtual round table on the need for equity, diversity, inclusivity, indigenization and accessibility (EDIIA) in cancer care and clinical trials. The goal of this roundtable is to help participants think about barriers experienced by cancer patients in Canada and how they can positively impact equity, diversity, and inclusion when working with patients and their families to improve their cancer care and clinical trial experience. Following the discussion, participants will have the opportunity to ask our panelists questions.
 
We are honoured to bring together Dr. Jennifer Bell, Mr. Tristan Bilash, and Dr. Aisha Lofters to guide us in this conversation. 
 
 

About the speakers

aishaloftersAisha Lofters

Aisha is a scientist at the Women's College Research Institute (WCRI), adjunct senior scientist at IC/ES, and an Associate Professor in the Department of Family and Community Medicine at the University of Toronto. She previously held a New Investigator Award from the Canadian Institutes of Health Research and is the Medical Director and Chair in Implementation Science at the Peter Gilgan Centre for Women’s Cancers at Women’s College Hospital in partnership with the Canadian Cancer Society. She was recently the recipient of the 2021 Canadian Cancer Society Inclusive Excellence Award. Her research program focusses on improving quality of care in cancer screening and prevention, particularly for populations that experience marginalization, through a variety of methods including community-partnered approaches. 

jenniferbellJennifer Bell

Dr. Jennifer A.H. Bell, MA, PhD, is a Senior Bioethicist and Director of Bioethics Research in the Department of Clinical and Organizational Ethics, and Research Scientist in the Princess Margaret Cancer Centre Department of Supportive Care Research Division at the University Health Network, Toronto, Canada. She is an Assistant Professor in the Department of Psychiatry and Dalla Lana School of Public Health, and Member of the Joint Centre for Bioethics at the University of Toronto. Jennifer’s program of research brings an equity and social justice perspective to addressing emerging ethical issues at the frontier of cancer care, including the ethics of clinical trials and novel therapeutics.

tristan bilash

 

 

Tristan Bilash

Tristan (he/him) is a stage 3C ovarian cancer survivor, transgender man, oncology social worker, writer, speaker, researcher, national 2SLGBTQIA+ representative for the Canadian Association of Psychosocial Oncology (CAPO) Advocacy Committee, a proud volunteer community partner with QueeringCancer.ca, and a friend and advisor to the World Ovarian Cancer Coalition.

Tristan has presented at numerous provincial, national, and international events including: keynote speaker at the Canadian Association of Psychosocial Oncology (CAPO)’s 2020 National Conference, presenter at the Society of Gynecologic Oncology (SGO)’s Allied Health Meeting in Chicago (2022), an expert panelist for “Frontiers in Gynaecological Oncology Roundtable” pre-congress event at the European Society of Gynaecological Oncology (ESGO)’s Annual Congress in Berlin, Germany (2022), a twice-featured speaker at Cancer Care Manitoba’s 2023 Health Equity Week, and presenter at the Cancer Nurses Society of Australia’s Annual Congress 2023.&

Tristan’s story is featured in the journal article, “Spare Parts: Navigating Ovarian Cancer As A Transgender Man” which he co-authored with his friend and colleague, Dr. Lauren Walker (Adjunct Associate Professor, Department of Oncology, Department of Psychology, University of Calgary). “Spare Parts” is published in the Journal of Clinical Oncology (Volume 40, Issue 9).